Clarus Ventures

Clear Vision for Healthcare Investing

  • Investor Login  
  • Home
  • About Us
  • Team
  • Portfolio
  • Investment News
  • Buzz & Events
  • Contact Us

 

News

05.16.2013
Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting.

05.15.2013
NanoString Technologies Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer.

More News >

Copyright © 2013 Clarus Ventures, LLC - All Rights Reserved